This content is machine translated Type 2 diabetes Cardiovascular optimized therapy up-to-date The current ESC guideline recommends blood glucose-lowering substances with a proven cardiovascular benefit for certain risk groups among type 2 diabetics. In type 2 diabetes (T2D) and atherosclerotic cardiovascular disease…
View Post 7 min This content is machine translated SCORE2 diabetes 10-year estimate of cardiovascular risk in type 2 diabetes. To develop and validate a recalibrated prediction model (SCORE2-Diabetes) to estimate the 10-year risk of cardiovascular disease in individuals aged over 40 years with type 2 diabetes in four different…
